Hemophilia gene therapy represents a groundbreaking shift in the landscape of hemophilia treatment, offering hope to the thousands suffering from this genetic disorder.By targeting the root cause of hemophilia B, gene therapy, specifically Hemgenix therapy, introduces a corrected gene that enables the body to produce the essential clotting factor IX, thereby significantly reducing the need for frequent injections.